Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide added to nifedipine for postpartum hypertension in women with preeclampsia
IRCT20191031045289N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in preeclampsia and hypertension (HTN) comparing Nifedipine + furosemide with Nifedipine alone (2 arms). Primary endpoint: Faster control of blood pressure in the postpartum period. Started Aug 2020; status: completed.
02
Drugs
furosemidenifedipine
03
Conditions
preeclampsiahypertension (HTN)
Beyond the preview
Go deeper on IRCT20191031045289N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191031045289N2.